| 10/30/25 20:00 | 10/28/25 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 2 | M.d | 614 | 18.41 | 0 | 33 | 68 | 82 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 20:00 | 10/28/25 | JANX | Janux Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 2 | S.d | -614 | 18.41 | 0 | -33 |  | 82 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 19:02 | 10/28/25 | ARQT | Arcutis Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watanabe Todd | CA | DO | See Rema | 4 | S.m | -2,229 | 20.89 | 0 | -107 |  | 1,135 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:09 | 9/9/25 | PAHC | Phibro Animal Health Corp | DE | Health | Drug | Pharmaceutical Preparations | Bendheim Jack | NJ | DOT | P,CEO | 6 | S.dm | -3,855 | 40.56 | 0 | -95 |  | 91 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:06 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 2 | M.d | 40 | 2.74 | 0 | 15 | 50 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:06 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | 2 | S.d | -40 | 2.74 | 0 | -15 |  | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:02 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 2 | M.d | 47 | 3.29 | 0 | 14 | 39 | 51 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:02 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | 2 | S.d | -47 | 3.29 | 0 | -14 |  | 51 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:01 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 2 | M.d | 52 | 3.29 | 0 | 16 | 26 | 77 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:01 | 10/30/25 | NRIX | Nurix Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | 2 | S.d | -52 | 3.29 | 0 | -16 |  | 77 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 18:00 | 10/28/25 | BGMS | Bio Green Med Solution, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Yap Kim Choy | N8 | T |  | 3 | S | -316 | 2.07 | 0 | -153 |  | 385 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:47 | 10/28/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 5 | M.dm | 1,061 | 23.12 | 0 | 46 |  | 31 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:47 | 10/28/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 5 | S.dm | -1,061 | 23.12 | 0 | -46 |  | 31 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:45 | 10/28/25 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Dube Eric M | CA | DO | CEO | 2 | M.dm | 5,494 | 22.89 | 0 | 240 | 134 | 419 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:45 | 10/28/25 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Dube Eric M | CA | DO | CEO | 2 | S.dm | -5,494 | 22.89 | 0 | -240 |  | 419 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:45 | 10/28/25 | TVTX | Travere Therapeutics, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Heerma Peter | CA | O | Chief Co | 1 | S | -80 | 30.00 | 0 | -3 |  | 125 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:44 | 10/28/25 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 10 | M.d | 5,650 | 66.94 | 0 | 84 |  | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:44 | 10/28/25 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shulman Joseph | MA | O | Chief Te | 10 | S.d | -5,650 | 66.94 | 0 | -84 |  | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:37 | 8/21/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | M.d | 40,332 | 261.89 | 0 | 154 |  | 37 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:37 | 8/21/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 14 | S.d | -40,332 | 261.89 | 0 | -154 |  | 37 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:31 | 10/28/25 | MPLT | Maplight Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/S | G7 | T |  | 1 | P.d | 16,200 | 17.00 | 0 | 953 | 35 | 3,687 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:30 | 10/27/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | 38 | M.dm | 80,468 | 271.85 | 0 | 296 | 85 | 644 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:30 | 10/27/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | 38 | S.dm | -80,468 | 271.85 | 0 | -296 |  | 644 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 16:25 | 9/2/25 | CYTK | Cytokinetics Inc |  | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 6 | S | -1,574 | 52.48 | 0 | -30 |  | 387 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/30/25 08:49 | 10/28/25 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jaen Juan C. | CA | O | P | 1 | S.m | -2,011 | 20.76 | 0 | -97 |  | 1,459 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 20:43 | 10/23/25 | TTRX | Turn Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chesed Abraham | CA | H | Board Ob | 1 | P | 66 | 4.60 | 0 | 14 | 1 | 1,447 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 19:22 | 10/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | D |  | 1 | S.m | -286 | 1.62 | 0 | -177 |  | 4,133 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 19:21 | 10/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures 2014, L.P. | MA | T |  | 1 | S.m | -446 | 1.62 | 0 | -276 |  | 6,443 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 19:21 | 10/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gadicke Ansbert | MA | T |  | 1 | S.m | -446 | 1.62 | 0 | -276 |  | 6,443 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 17:10 | 10/27/25 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCormick Frank | CA | D |  | 3 | S.d | -4,922 | 32.89 | 0 | -150 |  | 963 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 17:04 | 8/18/25 | SER | Serina Therapeutics, Inc. | AL | Health | Drug | Pharmaceutical Preparations | Moreadith Randall | AL | O | Chief Sc | 16 | M.dm | 503 | 3.13 | 0 | 161 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 17:04 | 8/18/25 | SER | Serina Therapeutics, Inc. | AL | Health | Drug | Pharmaceutical Preparations | Moreadith Randall | AL | O | Chief Sc | 16 | S.dm | -503 | 3.13 | 0 | -161 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:31 | 10/27/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shair Matthew | MA | D |  | 1 | S.m | -6,015 | 100.26 | 0 | -60 |  | 1,586 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:30 | 10/27/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Adair Jason | NC | O | Chief Bu | 5 | S.dm | -841 | 19.68 | 0 | -43 |  | 176 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:30 | 10/27/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Boyle Dana | NC | O | Chief Ac | 3 | S | -62 | 23.85 | 0 | -3 |  | 187 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:24 | 10/27/25 | NUVB | Nuvation Bio Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hattersley Gary | NY | O | Chief Sc | 2 | M.d | 676 | 3.38 | 0 | 200 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:24 | 10/27/25 | NUVB | Nuvation Bio Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hattersley Gary | NY | O | Chief Sc | 2 | S.d | -676 | 3.38 | 0 | -200 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:16 | 10/28/25 | MLPT | Maplight Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Catalyst4, Inc. | CA | T |  | 1 | P.d | 92,500 | 17.00 | 0 | 5,441 | 38 | 19,697 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:11 | 10/27/25 | PMVP | Pmv Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mack David Henry | NJ | DO | P,CEO | 1 | M.d | 302 | 1.37 | 0 | 221 | 24 | 1,127 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:02 | 10/27/25 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gheuens Sarah | MA | O | Chief Me | 2 | M.d | 228 | 34.47 | 0 | 7 | 12 | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 16:02 | 10/27/25 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gheuens Sarah | MA | O | Chief Me | 2 | S.d | -228 | 34.47 | 0 | -7 |  | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 08:54 | 10/28/25 | RCUS | Arcus Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Goeltz II Robert C. | CA | O | CFO | 1 | S | -100 | 20.00 | 0 | -5 |  | 92 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/29/25 08:00 | 10/23/25 | NVCT | Nuvectis Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mosseri Marlio Charles | N1 | T |  | 1 | P.m | 957 | 6.18 | 0 | 155 | 5 | 3,246 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 21:05 | 9/4/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT |  | 3 | P.m | 74,763 | 6.84 | 0 | 10,925 | 66 | 27,598 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 19:51 | 10/28/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mancini Marianna | CA | O | COO | 1 | S | -216 | 35.00 | 0 | -6 |  | 382 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 19:49 | 10/27/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rowland Charles A Jr | CA | D |  | 1 | S.d | -2,134 | 35.57 | 0 | -60 |  | 30 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 19:48 | 10/28/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lian Brian | CA | DO | P,CEO | 1 | S | -1,365 | 35.01 | 0 | -39 |  | 2,419 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 19:47 | 10/28/25 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zante Greg | CA | O | CFO | 1 | S | -216 | 35.00 | 0 | -6 |  | 174 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 18:45 | 10/24/25 | RNTX | Rein Therapeutics, Inc. |  | Health | Drug | Pharmaceutical Preparations | Voss Capital, LP | TX | T |  | 1 | P.m | 423 | 1.38 | 0 | 306 | 30 | 1,322 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 18:00 | 10/24/25 | BGMS | Bio Green Med Solution, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ong Yee Lung | N8 | T |  | 2 | S | -854 | 5.49 | 0 | -156 |  | 269 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 17:00 | 10/24/25 | CVKD | Cadrenal Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Szot Matthew K | FL | O | CFO | 6 | S.m | -328 | 14.03 | 0 | -23 |  | 31 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 17:00 | 10/24/25 | CVKD | Cadrenal Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pham Quang X | FL | DOT | CEO,CB | 6 | S.m | -312 | 14.04 | 0 | -22 |  | 413 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 16:30 | 10/27/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Benkowitz Michael | MD | O | P,COO | 18 | M.dm | 113,059 | 287.86 | 0 | 393 |  | 3 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 16:30 | 10/27/25 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Benkowitz Michael | MD | O | P,COO | 18 | S.dm | -113,059 | 287.86 | 0 | -393 |  | 3 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 16:10 | 10/25/25 | MRSN | Mersana Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bala Mohan | MA | O | SVP,Chie | 2 | M.d | 1 | 2.33 | 0 | 0 | 13 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 16:10 | 10/27/25 | MRSN | Mersana Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bala Mohan | MA | O | SVP,Chie | 2 | S.d | -1 | 2.33 | 0 | 0 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/28/25 08:03 | 10/24/25 | MBX | Mbx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawryluk P. Kent | IN | DO | P,CEO | 2 | M.d | 867 | 4.27 | 0 | 203 | 22 | 1,133 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 21:30 | 10/23/25 | CRMD | Cormedix Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaplan Myron | NJ | D |  | 1 | P | 276 | 11.02 | 0 | 25 | 12 | 231 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 19:56 | 10/27/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Accardi Mario Alberto | X0 | O | P,Orexin | 5 | M.d | 595 | 17.94 | 0 | 33 | 19 | 206 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 19:56 | 10/27/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Accardi Mario Alberto | X0 | O | P,Orexin | 5 | S.d | -595 | 17.94 | 0 | -33 |  | 206 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 19:24 | 10/23/25 | RANI | Rani Therapeutics Holdings, Inc. | CA | Health | Drug | Pharmaceutical Preparations | Imran Mir A | CA | DT |  | 1 | P.d | 1,260 | 0.6050 | 0 | 2,083 | 9 | 24,818 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 17:59 | 10/27/25 | CYTK | Cytokinetics Inc |  | Health | Drug | Pharmaceutical Preparations | Wierenga Wendell | CA | D |  | 2 | M.d | 300 | 34.34 | 0 | 9 | 37 | 32 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 17:59 | 10/27/25 | CYTK | Cytokinetics Inc |  | Health | Drug | Pharmaceutical Preparations | Wierenga Wendell | CA | D |  | 2 | S.d | -300 | 34.34 | 0 | -9 |  | 32 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 17:19 | 10/23/25 | PMVP | Pmv Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T |  | 4 | S.d | -12,892 | 1.01 | 0 | -12,806 |  | 14,447 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:30 | 10/23/25 | VRDN | Viridian Therapeutics, Inc.De | DE | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT |  | 2 | P | 16,008 | 20.77 | 0 | 771 | 14 | 6,123 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:23 | 10/24/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohen Yuval | MA | DO | CEO | 2 | M.dm | 589 | 10.66 | 0 | 55 | 67 | 138 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:23 | 10/24/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohen Yuval | MA | DO | CEO | 2 | S.dm | -589 | 10.66 | 0 | -55 |  | 138 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:22 | 10/24/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moran Sean F. | MA | O | CFO | 2 | M.d | 276 | 10.64 | 0 | 26 | 55 | 73 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:22 | 10/24/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Moran Sean F. | MA | O | CFO | 2 | S.d | -276 | 10.64 | 0 | -26 |  | 73 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/27/25 16:15 | 10/23/25 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Third Rock Ventures Iv, L.P. | MA | T |  | 6 | S.m | -26,351 | 7.59 | 0 | -3,473 |  | 15,759 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:18 | 10/22/25 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | 10X Fund, L.P. | GA | T |  | 1 | S | -247 | 4.94 | 0 | -50 |  | 5,872 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:00 | 10/23/25 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | D |  | 1 | S | -125 | 0.8100 | 0 | -155 |  | 104 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:00 | 10/22/25 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | 1 | S.m | -28 | 0.8297 | 0 | -33 |  | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:00 | 10/22/25 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | D |  | 1 | S | -40 | 0.8300 | 0 | -48 |  | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:00 | 10/22/25 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | 1 | S | -39 | 0.8300 | 0 | -47 |  | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 20:00 | 10/22/25 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kharabi Darius | MA | O | CHIEF BU | 1 | S | -17 | 0.8300 | 0 | -21 |  | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 19:19 | 6/6/25 | BOLT | Bolt Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nemec Sarah | CA | O | SVP,Fina | 1 | P | 1 | 5.50 | 0 | 0 | 1 | 24 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 19:18 | 6/6/25 | BOLT | Bolt Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quinn William P. | CA | DO | P,CEO,CF | 1 | P | 1 | 5.50 | 0 | 0 | 0 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 16:56 | 10/22/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hughes Steven George | CA | O | Chief Me | 12 | M.d | 4,586 | 30.92 | 0 | 148 |  | 39 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 16:56 | 10/22/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hughes Steven George | CA | O | Chief Me | 12 | S.d | -4,586 | 30.92 | 0 | -148 |  | 39 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 16:30 | 10/23/25 | ALZN | Alzamend Neuro, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McGrath Lynne Fahey | GA | D |  | 1 | S | 0 | 2.30 | 0 | 0 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/24/25 16:01 | 10/22/25 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ai Dmi LLC | NY | T |  | 1 | S | -59,873 | 80.47 | 0 | -744 |  | 2,814 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 21:06 | 10/21/25 | SMMT | Summit Therapeutics Inc. |  | Health | Drug | Pharmaceutical Preparations | Xia Yu | FL | D |  | 1 | P | 10,000 | 18.74 | 0 | 534 | 2 | 32,057 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 21:03 | 10/23/25 | TTRX | Turn Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Chaudhary Zuraiz | CA | O | See Rema | 1 | P | 25 | 4.95 | 0 | 5 |  | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 21:01 | 10/23/25 | TTRX | Turn Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Golden Arthur F | CA | D |  | 1 | P | 100 | 4.95 | 0 | 20 | 202 | 30 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 19:49 | 10/21/25 | NEUP | Neuphoria Therapeutics Inc. | C3 | Health | Drug | Pharmaceutical Preparations | Lynx1 Capital Management LP | PR | T |  | 1 | P | 3,283 | 5.14 | 0 | 639 | 271 | 875 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 18:00 | 10/21/25 | BGMS | Bio Green Med Solution, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitters Diversified Berhad | N8 | T |  | 5 | S | -1,777 | 4.23 | 0 | -420 |  | 557 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 17:10 | 10/22/25 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Martins Ryan | CA | O | CFO | 1 | M.d | 256 | 3.17 | 0 | 81 | 31 | 339 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 16:20 | 10/21/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Timothy Eugene | MA | O | CFO | 4 | M.d | 1,721 | 22.14 | 0 | 78 | 83 | 171 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 16:20 | 10/21/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sullivan Timothy Eugene | MA | O | CFO | 4 | S.d | -1,721 | 22.14 | 0 | -78 |  | 171 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 16:08 | 9/10/25 | SMMT | Summit Therapeutics Inc. |  | Health | Drug | Pharmaceutical Preparations | Duggan Robert W | FL | DOT | Co-CEO | 2 | P.m | 6,485 | 17.76 | 0 | 365 | 0 | 606,106 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/23/25 16:06 | 9/10/25 | SMMT | Summit Therapeutics Inc. |  | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | FL | DOT | Co-CEO | 2 | P.m | 6,485 | 17.76 | 0 | 365 | 0 | 606,106 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 19:20 | 10/20/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 5 | S.m | -771 | 20.56 | 0 | -38 |  | 940 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 18:57 | 10/20/25 | RANI | Rani Therapeutics Holdings, Inc. | CA | Health | Drug | Pharmaceutical Preparations | South Cone Investments Limited Partnership | F3 | T |  | 1 | S.m | -15,711 | 2.65 | 0 | -5,923 |  | 2,379 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:39 | 8/26/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cloonan Michael | MA | DO | P,CEO | 10 | M.dm | 7,550 | 18.87 | 0 | 400 | 271 | 547 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:39 | 8/26/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cloonan Michael | MA | DO | P,CEO | 10 | S.dm | -7,550 | 18.87 | 0 | -400 |  | 547 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:09 | 10/20/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 3 | M.dm | 11,004 | 20.18 | 0 | 545 |  | 222 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:09 | 10/20/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | X0 | DO | CB,CEO | 3 | S.dm | -11,004 | 20.18 | 0 | -545 |  | 222 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:06 | 10/20/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 7 | M.dm | 3,814 | 24.49 | 0 | 156 |  | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 17:06 | 10/20/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 7 | S.dm | -3,814 | 24.49 | 0 | -156 |  | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 16:32 | 10/20/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Miller Deborah Ann | MA | O | GC | 4 | M.dm | 3,242 | 49.12 | 0 | 66 |  | 49 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 16:32 | 10/20/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Miller Deborah Ann | MA | O | GC | 4 | S.dm | -3,242 | 49.12 | 0 | -66 |  | 49 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 16:15 | 10/20/25 | SPRB | Spruce Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gharib Samir M. | CA | O | P,CFO | 1 | M.d | 0 | 0.00 | 0 | 2 | 51 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/22/25 16:15 | 10/20/25 | SPRB | Spruce Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Szwarcberg Javier B. | CA | DO | CEO | 1 | M.d | 0 | 0.00 | 0 | 5 | 102 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 18:18 | 9/9/25 | CYTK | Cytokinetics Inc |  | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 12 | M.d | 722 | 29.84 | 0 | 24 | 21 | 141 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 18:18 | 9/9/25 | CYTK | Cytokinetics Inc |  | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 12 | S.d | -722 | 29.84 | 0 | -24 |  | 141 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 18:13 | 10/17/25 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 6 | S.m | -763 | 20.35 | 0 | -38 |  | 929 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 17:12 | 10/21/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Bruce | MA | D |  | 5 | S.m | -22,086 | 31.62 | 0 | -698 |  | 3,615 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 16:54 | 10/20/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Altmeyer Anne | MA | D |  | 2 | M.d | 27 | 12.65 | 0 | 2 | 52 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 16:54 | 10/20/25 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Altmeyer Anne | MA | D |  | 2 | S.d | -27 | 12.65 | 0 | -2 |  | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 11:56 | 10/19/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Forbes William P | NC | O | EVP,Chie | 2 | M.d | 0 | 0.00 | 0 | 16 | 11 | 155 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 11:42 | 10/19/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Duarte IRA | NC | O | EVP,CFO | 2 | M.d | 0 | 0.00 | 0 | 16 | 10 | 168 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/21/25 11:23 | 10/19/25 | HRTX | Heron Therapeutics, Inc. /De/ | DE | Health | Drug | Pharmaceutical Preparations | Collard Craig A | NC | DO | CEO | 2 | M.d | 0 | 0.00 | 0 | 49 | 11 | 488 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 20:00 | 9/12/25 | BYSI | Beyondspring Inc. |  | Health | Drug | Pharmaceutical Preparations | Decheng Capital China Life Sciences Usd Fund Iii, L.P. | CA | T |  | 17 | S.m | -2,020 | 2.36 | 0 | -855 |  | 4,488 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 19:13 | 10/17/25 | JNJ | Johnson & Johnson | NJ | Health | Drug | Pharmaceutical Preparations | Reed John C | NJ | O | EVP,Inno | 2 | M.d | 7,616 | 175.31 | 0 | 43 |  | 11 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 19:13 | 10/17/25 | JNJ | Johnson & Johnson | NJ | Health | Drug | Pharmaceutical Preparations | Reed John C | NJ | O | EVP,Inno | 2 | S.d | -7,616 | 175.31 | 0 | -43 |  | 11 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 18:58 | 10/16/25 | LVTX | Lava Therapeutics Nv | P7 | Health | Drug | Pharmaceutical Preparations | Cooperatieve Gilde Healthcare IV U.A. | P7 | T |  | 3 | S.m | -5,141 | 1.48 | 0 | -3,473 |  | 5,294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 18:00 | 10/15/25 | BGMS | Bio Green Med Solution, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kua Khai Loon | N8 | T |  | 3 | S.m | -815 | 5.03 | 0 | -162 |  | 385 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 16:44 | 10/17/25 | MBX | Mbx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hoerter Steven L. | IN | D |  | 1 | P | 265 | 13.25 | 0 | 20 |  | 20 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/20/25 09:11 | 10/17/25 | GOVX | Geovax Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spencer John N Jr | GA | D |  | 1 | P | 5 | 0.5498 | 0 | 10 | 88 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 21:00 | 10/15/25 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,Immuno | 10 | M.dm | 81,836 | 12.11 | 0 | 6,758 |  | 1,654 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 21:00 | 10/15/25 | ROIV | Roivant Sciences Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Venker Eric | X0 | O | P,Immuno | 10 | S.dm | -81,836 | 12.11 | 0 | -6,758 |  | 1,654 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 17:53 | 9/12/25 | KROS | Keros Therapeutics, Inc. |  | Health | Drug | Pharmaceutical Preparations | Pontifax Management 4 G.P. (2015) Ltd. | L3 | T |  | 2 | P.d | 99,975 | 17.27 | 0 | 5,787 |  | 1,422 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:41 | 10/15/25 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bitterman Kevin | MA | D |  | 5 | S.m | -16,488 | 75.48 | 0 | -218 |  | 1,097 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:32 | 8/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | M.d | 8,152 | 50.32 | 0 | 162 | 186 | 249 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:32 | 8/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 6 | S.d | -8,152 | 50.32 | 0 | -162 |  | 249 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:31 | 8/29/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pelish Henry E. | MA | O | Chief Sc | 9 | M.dm | 3,975 | 55.21 | 0 | 72 |  | 66 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:31 | 10/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balcom Alexandra | MA | O | CFO | 8 | M.dm | 8,767 | 49.10 | 0 | 179 |  | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:31 | 10/15/25 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Balcom Alexandra | MA | O | CFO | 8 | S.dm | -8,767 | 49.10 | 0 | -179 |  | 62 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:28 | 10/16/25 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Margaret | NY | O | Chief Me | 1 | S | -29 | 21.07 | 0 | -1 |  | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:27 | 10/15/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 6 | M.d | 3,095 | 34.39 | 0 | 90 | 999% | 97 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:27 | 10/15/25 | RNA | Avidity Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 6 | S.d | -3,095 | 34.39 | 0 | -90 |  | 97 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:15 | 10/16/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Watson David O. | MA | O | GC | 4 | S | -910 | 26.01 | 0 | -35 |  | 204 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:10 | 10/16/25 | PRAX | Praxis Precision Medicines, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Adage Capital Management, L.P. | MA | T |  | 1 | S | -33,198 | 105.76 | 0 | -314 |  | 4,422 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:05 | 10/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Samayoa Phillip | MA | O | CHIEF SC | 1 | M.d | 0 | 0.00 | 0 | 0 | 1 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:05 | 10/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | McDonough Geoff | MA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 1 | 0 | 187 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:05 | 10/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Howze Yalonda | MA | O | GC | 1 | M.d | 0 | 0.00 | 0 | 0 | 17 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:05 | 10/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Paone Antoinette | MA | O | COO | 1 | M.d | 0 | 0.00 | 0 | 0 | 5 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 16:05 | 10/15/25 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Conway Kevin John | MA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 0 | 3 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 14:01 | 10/15/25 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jung Cassie | NJ | O | COO | 4 | M.d | 959 | 4.68 | 0 | 205 | 254 | 285 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 14:01 | 10/15/25 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jung Cassie | NJ | O | COO | 4 | S.d | -959 | 4.68 | 0 | -205 |  | 285 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 14:01 | 10/15/25 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kraus Carl N | NJ | O | Chief Me | 1 | S | -142 | 7.00 | 0 | -20 |  | 282 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/17/25 14:00 | 10/15/25 | AQST | Aquestive Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Boyd Peter E. | NJ | O | See Rema | 3 | S | -213 | 6.07 | 0 | -35 |  | 288 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:16 | 10/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Swayze Eric | CA | O | EVP Rese | 6 | M.dm | 4,281 | 59.14 | 0 | 72 |  | 37 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:16 | 10/16/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Swayze Eric | CA | O | EVP Rese | 6 | S.dm | -4,281 | 59.14 | 0 | -72 |  | 37 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:16 | 10/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Parshall B Lynne | CA | D |  | 3 | S | -1,587 | 52.89 | 0 | -30 |  | 86 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:16 | 10/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | 4 | M.dm | 1,129 | 50.38 | 0 | 22 |  | 17 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:16 | 10/15/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | 4 | S.dm | -1,129 | 50.38 | 0 | -22 |  | 17 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:15 | 10/14/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Birchler Brian | CA | O | EVP,Corp | 2 | M.dm | 3,009 | 62.95 | 0 | 48 | 530 | 57 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 20:15 | 10/14/25 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Birchler Brian | CA | O | EVP,Corp | 2 | S.dm | -3,009 | 62.95 | 0 | -48 |  | 57 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 18:14 | 10/15/25 | AARD | Aardvark Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lee Tien-Li | CA | DOT | CEO | 4 | M.dm | 335 | 6.93 | 0 | 48 | 2 | 3,019 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 18:12 | 10/15/25 | AARD | Aardvark Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jones Bryan | CA | O | COO | 1 | M.d | 5 | 4.24 | 0 | 1 |  | 1 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:41 | 10/15/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 4 | M.dm | 1,290 | 12.53 | 0 | 103 | 103 | 203 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:41 | 10/15/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 4 | S.dm | -1,290 | 12.53 | 0 | -103 |  | 203 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:35 | 10/14/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 14 | M.dm | 16,140 | 24.40 | 0 | 661 |  | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:35 | 10/14/25 | KNSA | Kiniksa Pharmaceuticals International, Plc | X0 | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 14 | S.dm | -16,140 | 24.40 | 0 | -661 |  | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:30 | 10/15/25 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bredt David | MA | O | Chief Sc | 3 | S | -552 | 21.66 | 0 | -26 |  | 427 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:30 | 9/4/25 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ceesay Abraham | MA | DO | CEO | 3 | S | -2,357 | 26.28 | 0 | -90 |  | 722 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:21 | 10/7/25 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Glessner Coleen | MD | O | EVP,Qual | 1 | S | -306 | 10.00 | 0 | -31 |  | 144 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:15 | 10/16/25 | ABEO | Abeona Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Seshadri Vishwas | OH | DO | CEO | 2 | S.m | -236 | 5.31 | 0 | -45 |  | 1,190 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:13 | 8/15/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 8 | M.dm | 1,548 | 13.34 | 0 | 116 |  | 111 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:13 | 8/15/25 | CNTA | Centessa Pharmaceuticals Plc | X0 | Health | Drug | Pharmaceutical Preparations | Hussain Iqbal J | X0 | O | GC | 8 | S.dm | -1,548 | 13.34 | 0 | -116 |  | 111 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/16/25 16:01 | 10/14/25 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Militello John | NJ | O | See Rema | 3 | S.m | -139 | 3.76 | 0 | -37 |  | 67 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 20:12 | 10/10/25 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dunlop A. Sinclair | MA | D |  | 3 | S | -2,153 | 23.08 | 0 | -93 |  | 223 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 19:04 | 10/13/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Adam Scott | PA | O | CFO,Secr | 1 | S | -452 | 42.01 | 0 | -11 |  | 117 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 19:04 | 10/13/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Congleton Jon | PA | DO | CEO | 1 | S | -644 | 42.67 | 0 | -15 |  | 831 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 19:04 | 10/15/25 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | 4 | S.d | -1,009 | 25.58 | 0 | -39 |  | 93 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:47 | 10/15/25 | ALKS | Alkermes Plc. |  | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 2 | M.d | 380 | 27.18 | 0 | 14 | 23 | 74 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:47 | 10/15/25 | ALKS | Alkermes Plc. |  | Health | Drug | Pharmaceutical Preparations | Hopkinson Craig C. | MA | O | EVP R,D, | 2 | S.d | -380 | 27.18 | 0 | -14 |  | 74 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:31 | 10/10/25 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D |  | 6 | M.d | 604 | 45.76 | 0 | 13 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:31 | 10/10/25 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D |  | 6 | S.d | -604 | 45.76 | 0 | -13 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:00 | 10/13/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 2 | M.dm | 561 | 11.33 | 0 | 49 | 19 | 310 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 18:00 | 10/13/25 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 2 | S.dm | -561 | 11.33 | 0 | -49 |  | 310 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 17:15 | 10/14/25 | QNRX | Quoin Pharmaceuticals, Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Langer Dennis | VA | D |  | 1 | P.d | 129 | 8.49 | 0 | 15 | 999% | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:36 | 10/10/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Schundler Russell | NC | O | GC | 4 | M.d | 214 | 14.29 | 0 | 15 | 3 | 595 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:36 | 10/13/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Schundler Russell | NC | O | GC | 4 | S.d | -214 | 14.29 | 0 | -15 |  | 595 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:34 | 10/10/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Kaseta Michael | NC | O | CFO,COO | 6 | M.d | 1,429 | 20.15 | 0 | 71 | 23 | 376 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:34 | 10/13/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Kaseta Michael | NC | O | CFO,COO | 6 | S.d | -1,429 | 20.15 | 0 | -71 |  | 376 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:34 | 10/10/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Moomaw Scott | NC | O | Chief Co | 4 | M.d | 2,138 | 26.54 | 0 | 81 | 108 | 155 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:34 | 10/13/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Moomaw Scott | NC | O | Chief Co | 4 | S.d | -2,138 | 26.54 | 0 | -81 |  | 155 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:33 | 10/10/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Saggar Rajeev | NC | O | Chief Me | 3 | M.d | 682 | 23.63 | 0 | 29 | 13 | 250 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:33 | 10/13/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Saggar Rajeev | NC | O | Chief Me | 3 | S.d | -682 | 23.63 | 0 | -29 |  | 250 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:32 | 10/6/25 | SPRB | Spruce Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Parkman Healthcare Partners LLC | CT | T |  | 4 | P | 19 | 18.53 | 0 | 1 | 999% | 1 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:32 | 10/6/25 | SPRB | Spruce Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Parkman Healthcare Partners LLC | CT | T |  | 4 | S | -19 | 18.53 | 0 | -1 |  | 1 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:31 | 9/2/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Jeffs Roger | NC | DO | CEO | 5 | S.dm | -13,848 | 96.00 | 0 | -144 |  | 2,752 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 16:30 | 10/13/25 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | Krepp Sarah | NC | O | Chief Hu | 2 | S | -46 | 24.03 | 0 | -2 |  | 143 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/15/25 13:24 | 10/15/25 | KROS | Keros Therapeutics, Inc. |  | Health | Drug | Pharmaceutical Preparations | Adar1 Capital Management, LLC | TX | T |  | 1 | S | -95,659 | 17.75 | 0 | -5,389 | -100 | 0 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 20:11 | 10/10/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 6 | M.dm | 5,201 | 27.53 | 0 | 189 | 56 | 526 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 20:11 | 10/10/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 6 | S.dm | -5,201 | 27.53 | 0 | -189 |  | 526 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 19:49 | 10/13/25 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Cook Meredith | MN | O | SVP,GC,S | 3 | S | -111 | 92.46 | 0 | -1 |  | 76 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 17:16 | 10/9/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nunn Jason Raleigh | PA | D |  | 1 | P | 1,200 | 19.00 | 0 | 63 | 2 | 3,120 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 17:14 | 10/9/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sr One Capital Management, LLC | PA | T |  | 1 | P | 2,400 | 19.00 | 0 | 126 | 3 | 5,038 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 16:31 | 10/9/25 | VSTM | Verastem, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Bunn Paul A. | MA | D |  | 1 | S | -75 | 9.06 | 0 | -8 |  | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 16:01 | 10/10/25 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Waddill William D. | CA | D |  | 4 | M.d | 1,557 | 48.66 | 0 | 32 |  | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 16:01 | 10/10/25 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Waddill William D. | CA | D |  | 4 | S.d | -1,557 | 48.66 | 0 | -32 |  | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 16:00 | 10/10/25 | LLY | Eli Lilly & Co | IN | Health | Drug | Pharmaceutical Preparations | Lilly Endowment Inc | IN | T |  | 12 | S | -982,956 | 816.64 | 0 | -1,204 |  | 95,630 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 12:15 | 10/13/25 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Horn Howard | CA | O | CFO | 1 | S | -250 | 31.51 | 0 | -8 |  | 98 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/14/25 08:59 | 10/9/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | MA | D |  | 1 | P | 2,250 | 19.19 | 0 | 117 | 5 | 2,619 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/10/25 19:48 | 10/8/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Graham G. Walmsley | CA | D |  | 1 | M.d | 1,866 | 20.55 | 0 | 91 | 8 | 1,293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 10/10/25 19:17 | 10/10/25 | ZVRA | Zevra Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | McFarlane Neil F. | FL | DO | P,CEO | 2 | M.d | 211 | 3.03 | 0 | 70 | 46 | 222 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |